Esthetic, Clinical and Radiographic Outcomes of Immediate and Delayed Implant Placement

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-80
SponsorSun Yat-sen University

About this trial

The aim of this prospective cohort study is to compare the esthetic, clinical and patient-centered outcomes following immediate and delayed implant placement protocols.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

At least 18 years old and able to understand an informed consent

Adequate oral hygiene to allow for implant therapy consistent with standards of care.

Missing a single tooth in the maxillary anterior region

Presence of adjacent natural teeth

Disqualifiers

Poor oral hygiene

Severe parafunctional habits, for example, bruxing and clenching

Presence of clinically active periodontal disease as expressed by probing pocket depths≥4 mm in combination with bleeding on probing.

Conditions that might lead to a possibly lowered regenerative capacity of the bone, for example, osteoporosis and Paget's disease

Trial design

Design model

Parallel

Treatments tested in this trial

  • Type 1 implant placement

    Procedure/Surgery

    Implant is placed immediately following tooth extraction in one surgical procedure

  • Type 3 implant placement

    Procedure/Surgery

    Implant is placed in the site which is left to heal for 3 months following tooth extraction

Treatment groups

40 Participants
are divided into 2 treatment groups
Group A: Type 1 implant placementActive comparator 1 intervention
Group B: Type 3 implant placementActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Pink and white esthetic scores (PES/WES)

Baseline will be at the time of implant placement.Pink and white esthetic scores (PES/WES) will be recorded at 0.5, 1.5, 3.5, 5.5, 7.5, 10.5 years after implant placement.

Time frame
Up to 10 years after baseline
2

Radiographic bone volume

Radiographic bone volume be assessed at pre-operation, 0 ,1.5, 1, 1.5, 3.5, 5.5, 7.5, 10.5 years after implant placement.

Time frame
Up to 10 years after baseline

Secondary outcomes

1

Implant survival

Implant survival will be assessed at 0.5, 1, 1.5, 3.5, 5.5, 7.5, 10.5 years after implant placement.

Time frame
Up to 10 years after baseline
2

Probing depth

Probing depth will be assessed at pre-operation, 0.5, 1, 1.5, 3.5, 5.5, 7.5, 10.5 years after implant placement.

Time frame
Up to 10 years after baseline
3

Modified plaque index

Modified plaque index will be assessed at pre-operation, 0.5, 1, 1.5, 3.5, 5.5, 7.5, 10.5 years after implant placement.

Time frame
Up to 10 years after baseline
4

Modified bleeding index

Modified bleeding index will be assessed at pre-operation, 0.5, 1, 1.5, 3.5, 5.5, 7.5, 10.5 years after implant placement.

Time frame
Up to 10 years after baseline

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.